Myslobodsky M S, Mansour R
Waking Sleeping. 1979 Jul;3(3):245-54.
Systemic administration of GABA-transaminase inhibitors, gamma-acetylenic GABA (100 mg/kg) or gamma-vanylic GABA (1200 mg/kg) produces behavioral picture of somnolence accompanied by EEG hypersynchronisation reminiscent of electrographic signs of petit mal epilepsy. Similarly, systemic administration of GABA antagonist, Picrotoxin (3--4 mg/kg) produces a short lasting period of sedation preceding the development of myoclonic jerks which is also accompanied by Wave-spike discharges. The role of GABA in sleep control is discussed. Although the area is not ready for firm conclusions, the results suggest that hyperactivity of GABA-ergic system as well as its hypoactivity could mediate pathological somnolence associated with different forms of epilepsy.
全身性给予γ-氨基丁酸转氨酶抑制剂、γ-乙炔基γ-氨基丁酸(100毫克/千克)或γ-乙烯基γ-氨基丁酸(1200毫克/千克)会产生嗜睡的行为表现,并伴有脑电图超同步化,这让人联想到小儿失神癫痫的脑电图特征。同样,全身性给予γ-氨基丁酸拮抗剂印防己毒素(3 - 4毫克/千克)会在肌阵挛性抽搐发作前产生一段短暂的镇静期,同时也伴有棘慢波放电。文中讨论了γ-氨基丁酸在睡眠控制中的作用。尽管该领域尚未得出确凿结论,但结果表明,γ-氨基丁酸能系统的功能亢进及其功能减退都可能介导与不同形式癫痫相关的病理性嗜睡。